Results 261 to 270 of about 6,708,642 (339)

Impact of APOE ε4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients With Cerebral Small Vessel Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin, Haocheng Yang, Feng Liu, Sihao Lin, Junru Hu, Jian Wang, Yulan Gou   +6 more
wiley   +1 more source

Comment on "Improving consenting practice in trauma and orthopaedics: A single centre original mixed methods study". [PDF]

Surg Pract Sci
Batra A, Kokiwar P, Aher P, Singh I.
europepmc   +1 more source

Informed consent for medication in persons with mental retardation and mental illness.

, 2002
Joan O’Sullivan, Breck Borcherding
openalex   +1 more source

The 21 Century Challenge to Autonomy and Informed Consent

, 2012
Dena S. Davis
openalex   +1 more source

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu, Oliver Robinson, Christina M. Lill, Anna Matton, Raquel Puerta, Pilar Sanz, Merce Boada, Agustín Ruiz, Lefkos Middleton, for the Alzheimer's Disease Neuroimaging Initiative   +9 more
wiley   +1 more source

Beyond the label: ethical and clinical implications of off-label drug use in pediatric emergency care. [PDF]

Ital J Pediatr
Colombo M, Plebani A, Agosti M.
europepmc   +1 more source

Beyond Consent: A Relational Model of Community Authorization for Genetically Modified Mosquito Trials in Developing Countries

, 2014
Lara El Zahabi
openalex   +1 more source

Informed Consent

Annals of Internal Medicine, 1993
openaire   +3 more sources

Autonomy and Consent in Biobanks [PDF]

, 2010
Schwartz, Peter H.
core  

The MMP‐9/TIMP‐1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To evaluate the utility of cerebrospinal fluid (CSF) biomarkers—matrix metalloproteinase‐9 (MMP‐9), tissue inhibitor of metalloproteinases‐1 (TIMP‐1), the MMP‐9/TIMP‐1 ratio, and osteopontin (OPN)—as indicators of blood–brain barrier (BBB) integrity and disease activity in people with relapsing–remitting multiple sclerosis (pwMS ...
Ivan Pavlovic, Ida Erngren, Kim Kultima, Anders Larsson, Malin Müller, Anna Wiberg, Joachim Burman   +6 more
wiley   +1 more source